Biotech

All Articles

Former Seagen chief executive officer introduces brand new start-up Ottimo Pharma

.After antibody-drug conjugate (ADC) expert Seagen was actually sold to Pfizer in 2015 for an immens...

Ironwood makes additional bid for $1B GI medication along with brand-new subgroup data

.On the heels of a stage 3 win that stopped working to impress capitalists, Ironwood Pharmaceuticals...

Novartis inks $150M bargain for autoimmune molecular glue

.Don't cease Monte Rosa Therapies now. The Boston-based biotech is having a ball after authorizing a...

Jade carves out officer crew with Chinook vets-- Chutes &amp Ladders

.Accept to today's Chutes &amp Ladders, our summary of notable management hirings, firings and retir...

Septerna goes social along with upsized offering of $288M

.Commemorating his firm's upsized going public (IPO), Septerna CEO Jeffrey Finer sounded the positio...

AbbVie brings in Richter richer, paying for $25M to form breakthrough contract

.AbbVie has come back to the source of its antipsychotic giant Vraylar seeking an additional hit, sp...

GenSight enters into ultimate weeks of cash runway as profits stream slips by of range

.GenSight Biologics is actually weeks away from lacking loan. Again. The biotech merely has adequate...

AZ licenses thrown away rare health condition medicine to Monopar Therapeutics

.Monopar Rehabs is actually recovering a drug coming from the dump of AstraZeneca's rare condition p...

Arcus' brand-new HIF-2a information in renal cancer cells mean potential edge over Merck's Welireg, analysts claim

.Along with brand new data out on Arcus Biosciences' speculative HIF-2a inhibitor, one group of anal...

Roche bets as much as $1B to increase Dyno genetics treatment shipment pact

.After creating a genetics treatment alliance along with Dyno Therapeutics in 2020, Roche is actuall...